Multicenter, prospective observational study to identify peripheral blood-derived epigenome markers correlated with blood trough value and adverse events of afatinib in EGFR mutation-positive non-small cell lung cancer patients
Not Applicable
- Conditions
- ung cancer
- Registration Number
- JPRN-UMIN000030939
- Lead Sponsor
- Toshiyuki Sawa Gifu City Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 11
Inclusion Criteria
Not provided
Exclusion Criteria
Idiopathic pulmonary fibrosis, interstitial pneumonia, pneumoconiosis, active radiation pneumonitis, drug pneumonia, etc. are complicated Active other malignancy HBs antigen positive HBs or HBc antibody positive and HBV-DNA positive HIV or HCV carrier Adjuvant chemotherapy Infection to need to treat with antibiotics or antifungal agent via intravenous administration Not obtain the consent of taking the sample Serious psychiatric disorder Women who are pregnant, nursing, or who plan to become pregnant and Men who plan to father a child while in this study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method